Editorial Commentary
Serum neurofilament light chain rate of change in Alzheimer’s disease: potentials applications and notes of caution
Abstract
Recent years have seen an increase of the use of imaging and fluid biomarkers as a key tool to help in the differential diagnosis of Alzheimer’s disease (AD), especially in its pre-dementia stages (1).
